Mold: The Hidden Cause of Gut Issues

Mold May Be Causing Your Gut Issues

Mold Toxicity Defined

Mold toxicity, also known as mold illness, refers to the adverse health effects resulting from exposure to mold and its toxic metabolites, known as mycotoxins. These toxic substances can infiltrate the body through airborne spores or contaminated food sources, leading to various detrimental health outcomes. Mycotoxins can trigger widespread inflammation, damage cellular structures, confuse the immune system, impair cellular communication, and much more. The impact of these toxins on gut health is particularly severe and warrants a detailed exploration.

Mold’s Impact on Gut Health

Mycotoxins can wreak havoc on gut health through several mechanisms, including altering the intestinal epithelium, disturbing the gut microbiome, reducing mucin production, activating the immune response, inducing oxidative stress, interfering with nutrient absorption, and causing cytotoxic effects.

Structural Changes to the Intestinal Lining

The intestinal lining (epithelium) is a critical component of the gastrointestinal tract, serving as a barrier that selectively permits the absorption of nutrients while preventing the entry of harmful substances into the bloodstream. This epithelial layer is maintained by tight junction proteins that create a cohesive and functional barrier. However, various external factors, such as mycotoxins, can compromise the integrity of these tight junctions, leading to a condition commonly referred to as “leaky gut.” This condition has significant implications for systemic health, as it facilitates the translocation of toxins and pathogens into the bloodstream, triggering systemic inflammation and a range of health issues.

The Role of the Intestinal Epithelium

The intestinal epithelium is composed of a single layer of cells that line the intestinal tract. These cells are connected by tight junctions, which are complexes of proteins that seal the space between adjacent epithelial cells. This barrier function is essential for maintaining the body’s internal environment, preventing the passage of harmful microorganisms, toxins, and antigens from the lumen of the gut into the underlying tissue and bloodstream.

Mechanisms of Tight Junction Damage

Mycotoxins, which are toxic compounds produced by certain types of fungi, have been identified as significant disruptors of intestinal barrier function. These toxins can impair the structure and function of tight junction proteins, such as claudins, occludin, and zonula occludens-1 (ZO-1). The disruption of these proteins leads to increased intestinal permeability. This pathological condition, often referred to as “leaky gut,” allows substances that are normally restricted to the intestinal lumen to pass freely into the bloodstream.

Consequences of Increased Intestinal Permeability

The increase in intestinal permeability has several detrimental effects on health. When the barrier function of the intestine is compromised, toxins and pathogens that penetrate the epithelium can induce a systemic inflammatory response. This inflammation is characterized by the activation of the immune system, which can lead to chronic inflammatory conditions. Moreover, the entry of pathogens into the bloodstream can cause infections and contribute to the development of autoimmune diseases.

Gut Dysbiosis

Gut dysbiosis refers to the imbalance in the gut microbiome, characterized by a disrupted ratio of beneficial to harmful bacteria. This condition is increasingly recognized as a critical factor in the pathogenesis of various health disorders. Among the numerous factors that can lead to gut dysbiosis, mycotoxins play a significant role. These toxic secondary metabolites produced by fungi can profoundly impact the composition and function of the intestinal microbiota. 

Mycotoxins and Gut Microbiota

Mycotoxins, such as aflatoxins, ochratoxins, and deoxynivalenol, are commonly found in contaminated food and feed products. When ingested, these compounds can disrupt the delicate balance of the gut microbiota. Studies have shown that mycotoxins can alter both the abundance and diversity of intestinal microflora. This disruption often leads to a decrease in beneficial bacteria such as Lactobacillus and Bifidobacterium, while promoting the overgrowth of pathogenic bacteria like Clostridium and Escherichia coli.

The mechanisms by which mycotoxins induce gut dysbiosis are multifaceted. They include direct toxic effects on bacterial cells, modulation of the immune response, and interference with gut barrier function. For instance, deoxynivalenol (DON) has been shown to disrupt tight junction proteins, leading to increased intestinal permeability, commonly known as “leaky gut.” This condition allows pathogens and toxins to translocate across the gut barrier, further exacerbating microbial imbalance and inflammation.

Health Implications of Gut Dysbiosis

The consequences of gut dysbiosis extend beyond the gastrointestinal tract. There is a growing body of evidence linking gut microbiota imbalances to a variety of health issues. Notably, gut dysbiosis has been associated with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), conditions characterized by chronic inflammation and altered gut motility.

Moreover, emerging research indicates that gut dysbiosis can influence mental health. The gut-brain axis, a bidirectional communication network between the gut and the brain, plays a crucial role in maintaining mental health. Dysbiosis can disrupt this axis, contributing to the development of anxiety and depression. This is thought to occur through mechanisms involving altered production of neurotransmitters, immune activation, and changes in vagus nerve signaling.

3. Reduction in Mucin Production

Mucin, a glycoprotein component of mucus, forms a critical protective barrier lining the gut epithelium. This mucosal layer is essential for maintaining intestinal homeostasis and protecting against pathogenic invasion. However, exposure to mycotoxins—secondary metabolites produced by fungi—can impair mucin production and secretion, thereby compromising the integrity of this barrier. The resultant mucin depletion not only heightens susceptibility to pathogens and toxins but also predisposes the gut to inflammation and infection. 

The gut mucosal barrier is crucial in protecting the intestinal epithelium from mechanical damage, pathogens, and toxins. Mucin, the primary component of this barrier, is secreted by goblet cells and is essential for maintaining the viscoelastic properties of mucus, which traps and clears harmful agents from the gut lumen. Disruption in mucin production and secretion can thus have profound implications for gut integrity and overall health.

Mechanisms of Mucin Production and Secretion

Mucin is synthesized in the endoplasmic reticulum of goblet cells and undergoes extensive post-translational modification in the Golgi apparatus, where it is glycosylated to form a complex glycoprotein. The fully formed mucin is then packaged into secretory granules and released into the gut lumen. The secretion of mucin is regulated by various factors, including cytokines, growth factors, and microbial signals.

Impact of Mycotoxins on Mucin Dynamics

Mycotoxins, such as aflatoxins, ochratoxins, and trichothecenes, have been shown to interfere with mucin production and secretion. These toxic compounds can induce oxidative stress, disrupt cellular signaling pathways, and alter gene expression in goblet cells. For instance, studies have demonstrated that mycotoxins can downregulate MUC2, the gene encoding the predominant mucin in the gut, thereby reducing mucin synthesis and secretion. This impairment leads to a thinner mucus layer, making the gut epithelium more vulnerable to pathogenic invasion and toxin exposure.

Consequences of Mucin Depletion

The reduction in mucin production compromises the gut barrier function, leading to increased permeability (often referred to as “leaky gut”). This condition allows pathogens and toxins to penetrate the epithelial layer, triggering inflammatory responses and increasing the risk of infections. Chronic mucin depletion is also associated with various gastrointestinal disorders, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and colorectal cancer.

Immune Activation and Inflammation

Mycotoxins, such as aflatoxins, ochratoxins, and trichothecenes, are commonly found in contaminated food products. When ingested, these toxins interact with the gut mucosa, a primary site for immune system activity. The gut-associated lymphoid tissue (GALT) is densely populated with immune cells, including macrophages, dendritic cells, and T-lymphocytes, which are crucial for maintaining immune surveillance and response.

Mechanisms of Immune Activation

Inflammatory Cascade

The release of pro-inflammatory cytokines initiates an inflammatory cascade, which involves the recruitment of additional immune cells to the site of toxin exposure. This process is marked by increased vascular permeability, allowing immune cells to migrate more effectively to the affected area. The sustained presence of these cytokines and immune cells can lead to chronic inflammation if the exposure to mycotoxins is prolonged or repetitive.

Chronic Inflammation and Health Implications

Chronic inflammation in the gut can disrupt the normal function of the gastrointestinal tract, leading to various disorders. Conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and celiac disease have been associated with persistent gut inflammation. Moreover, chronic inflammation has been implicated in the development of autoimmune diseases, where the body’s immune system erroneously attacks its own tissues.

Gastrointestinal Disorders

The continuous activation of immune cells and the resultant inflammation can cause structural and functional changes in the gut mucosa. This can lead to increased intestinal permeability, often referred to as “leaky gut syndrome,” allowing harmful substances to enter the bloodstream and exacerbate the inflammatory response. Patients with IBD and IBS frequently exhibit elevated levels of inflammatory markers in their gut tissues.

Autoimmune Diseases

Autoimmune diseases such as Crohn’s disease, rheumatoid arthritis, and type 1 diabetes have also been linked to chronic gut inflammation. The persistent inflammatory environment can alter immune regulation, causing the immune system to lose tolerance to self-antigens. This breakdown in immune tolerance is a hallmark of autoimmune disease pathogenesis.

Oxidative Stress

Oxidative stress is a condition characterized by an imbalance between the production of reactive oxygen species (ROS) and the body’s ability to counteract their harmful effects through neutralization by antioxidants. Mycotoxins, toxic secondary metabolites produced by fungi, are known to induce the production of ROS in various cell types, including intestinal cells. 

Impact of Oxidative Stress on Intestinal Cells

When ROS build up in intestinal cells, they can damage important molecules. DNA, the cell’s blueprint, is especially vulnerable, and damage can lead to mutations, breaks, and instability. While cells can try to repair this damage, ongoing harm may result in cell death or even cancer.

Proteins are also targets for ROS damage, which can change their structure and function. This can disrupt enzyme activity, signaling pathways, and gut barrier proteins like tight junctions. When these proteins are damaged, the gut barrier becomes weaker, allowing harmful substances to pass through.

Cell membranes, made of lipids, are another common target for ROS. Damage to these lipids, called lipid peroxidation, creates harmful byproducts like MDA and 4-HNE. These byproducts can further weaken membranes, causing cell breakdown and inflammation.

Oxidative Stress and Inflammation

Oxidative stress and inflammation are closely connected. Reactive oxygen species (ROS) can trigger pathways in the body, such as NF-κB and MAPKs, that lead to the production of inflammatory chemicals. These chemicals attract immune cells to areas of damage, increasing inflammation and creating a harmful cycle of more oxidative stress and inflammation.

When this cycle continues in the gut, it can cause serious problems like inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and even colorectal cancer. Learning how mycotoxins contribute to oxidative stress helps us understand these conditions better and shows the importance of reducing mycotoxin exposure and boosting antioxidant support to protect gut health.

Interference with Nutrient Absorption

Mycotoxins are secondary metabolites produced by molds such as Aspergillus, Fusarium, and Penicillium species. These toxic substances are commonly found in contaminated food and feed, posing a serious risk to human and animal health. The primary routes of exposure to mycotoxins are through ingestion, inhalation, and dermal contact. Among the various health issues caused by mycotoxins, their ability to interfere with the absorption of nutrients in the intestines is particularly concerning. This article reviews the existing literature on this topic and discusses the potential role of functional medicine in addressing the health challenges posed by mycotoxins.

Mechanisms of Nutrient Absorption Interference

The small intestine is the principal site for nutrient absorption in the human body. The integrity and functionality of the intestinal mucosa are essential for the efficient absorption of vitamins and minerals. Mycotoxins can disrupt this process through several mechanisms:

1. Damage to Intestinal Epithelial Cells: Mycotoxins such as deoxynivalenol (DON) can induce apoptosis (programmed cell death) in intestinal epithelial cells, leading to a compromised intestinal barrier and impaired nutrient absorption.
2. Alteration of Gut Microbiota: Certain mycotoxins can alter the composition of gut microbiota, which play a crucial role in the digestion and absorption of nutrients. Dysbiosis, or an imbalance in gut microbiota, can result in malabsorption and nutrient deficiencies.
3. Inhibition of Enzymatic Activity: Mycotoxins can inhibit the activity of digestive enzymes, which are necessary for the breakdown and absorption of nutrients. For example, ochratoxin A (OTA) has been shown to inhibit intestinal brush border enzymes.
4. Inflammation and Immune Response: Mycotoxins can trigger inflammatory responses in the intestines, which can further impair nutrient absorption. Inflammation can lead to increased intestinal permeability, commonly known as “leaky gut,” allowing toxins and partially digested food particles to enter the bloodstream.

Health Implications of Nutrient Deficiencies

Nutrient deficiencies resulting from mycotoxin exposure can have wide-ranging health implications. Essential vitamins and minerals play critical roles in various physiological processes, including:

• Immune Function: Deficiencies in vitamins such as A, C, and D, and minerals like zinc, can weaken the immune system, making the body more susceptible to infections.
• Bone Health: Calcium and vitamin D are vital for maintaining bone density and strength. Deficiencies in these nutrients can lead to conditions such as osteoporosis.
• Neurological Health: Vitamins B6, B12, and folate are essential for neurological function. Deficiencies can result in neurological disorders and cognitive impairments.
• Cardiovascular Health: Magnesium and potassium are important for cardiovascular health. Their deficiencies can lead to hypertension and other cardiovascular diseases.

Cytotoxic (Cell-killing) Effects

Mycotoxins, including aflatoxins, ochratoxins, trichothecenes, fumonisins, and zearalenone, exhibit potent cytotoxic properties, meaning that they kill cells. The primary mechanism of mycotoxin-induced cytotoxicity involves the disruption of cellular processes, leading to cell death or significant damage. Mycotoxins interfere with protein synthesis, DNA replication, and cellular respiration, resulting in apoptosis or necrosis of the affected cells.

Impact on Intestinal Epithelial Cells

The intestinal epithelium is a critical barrier that regulates nutrient absorption and prevents the entry of harmful substances. Mycotoxins compromise the integrity of this barrier by inducing cytotoxic effects on the epithelial cells. This disruption hampers the normal turnover and regeneration of the intestinal lining, impairing tissue repair mechanisms. The damage to the epithelial cells leads to increased intestinal permeability, often referred to as “leaky gut,” allowing the translocation of pathogens and toxins into the bloodstream.

Implications for Chronic Gut Health

The chronic exposure to mycotoxins and the resulting damage to intestinal epithelial cells contribute significantly to long-term gut health issues. The impaired barrier function and tissue repair mechanisms can lead to persistent inflammation and immune system activation. Over time, this chronic inflammatory state is associated with various gastrointestinal disorders, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and even colorectal cancer.

Mast Cell Activation Syndrome

Mold exposure is also linked to mast cell activation syndrome (MCAS), a condition characterized by the inappropriate activation of mast cells. Mast cells are part of the immune system and play a critical role in allergic responses and inflammation. In MCAS, these cells release excessive amounts of histamine and other inflammatory mediators, leading to symptoms such as gastrointestinal distress, skin rashes, and respiratory issues. MCAS can further exacerbate gut health problems, creating a vicious cycle of inflammation and immune dysfunction.

Addressing Mold and Mycotoxins in Gut Health
From a Functional Medicine Perspective

Functional medicine offers a comprehensive approach to mitigate the effects of mold and mycotoxins on the gut, focusing on detection and avoidance, detoxification, nutritional support, and anti-inflammatory strategies.

Detection and Avoidance

The first step in addressing mold and mycotoxins is identifying and minimizing exposure. This involves:

1. Dietary Modifications: Avoiding foods that are prone to mold contamination, such as certain nuts, grains, and dried fruits. Opting for fresh, organic produce and properly storing food to prevent mold growth can reduce dietary mycotoxin exposure.

2. Environmental Interventions: Ensuring a mold-free living environment by controlling humidity levels, promptly fixing water leaks, and using air purifiers can help minimize exposure to airborne mycotoxins.

Detoxification

Supporting the body’s natural detoxification pathways is crucial in eliminating accumulated mycotoxins. Functional medicine practitioners recommend:

1. Enhancing Liver Function: The liver is a primary organ for detoxification. Nutrients such as glutathione, N-acetylcysteine, and milk thistle can support liver health and its ability to process and excrete toxins.

2. Using Mycotoxin Binders: Supplements like activated charcoal and bentonite clay can bind to mycotoxins in the gut, preventing their absorption and facilitating their elimination through the digestive tract.

Nutritional Support

Targeted nutritional interventions are essential for repairing and maintaining gut health. Key components include:

1. Probiotics and Prebiotics: Probiotics, such as Lactobacillus and Bifidobacterium strains, help maintain a healthy gut microbiome. Prebiotics, like inulin and fructooligosaccharides, provide nourishment for beneficial bacteria.

2. Specific Nutrients: Nutrients such as glutamine, an amino acid that fuels intestinal cells, and zinc, which supports immune function and mucosal integrity, are vital for gut repair and regeneration.

Anti-inflammatory Strategies

Chronic inflammation can exacerbate gut issues. Implementing anti-inflammatory dietary and lifestyle changes is essential for reducing inflammation and supporting immune function:

1. Dietary Changes: Eliminating pro-inflammatory foods like gluten, processed foods, and certain additives while increasing intake of anti-inflammatory foods rich in omega-3 fatty acids and polyphenols can significantly reduce inflammation.

2. Stress Management: Chronic stress negatively impacts gut barrier function. Techniques such as mindfulness, meditation, and regular physical activity can help manage stress and reduce its impact on gut health.

Implications for Functional Medicine

Functional medicine emphasizes treating the underlying causes of diseases rather than just addressing symptoms. In the context of gut health and mycotoxin exposure, this involves:

1. Restoring Intestinal Barrier Integrity: Dietary interventions to eliminate inflammatory foods and supplementation with nutrients that support the gut lining, such as glutamine and zinc, can help restore the intestinal barrier.

2. Supporting a Healthy Gut Microbiome: Probiotics and prebiotics play a crucial role in maintaining a balanced gut microbiome, which is essential for overall gut health.

3. Reducing Systemic Inflammation: Anti-inflammatory strategies, including dietary changes and lifestyle modifications, can help reduce chronic inflammation and support overall health.

Mechanisms of Mycotoxin-Induced Oxidative Stress

Mycotoxins like aflatoxins, ochratoxins, and deoxynivalenol can induce oxidative stress by generating reactive oxygen species (ROS) in intestinal cells. This process involves:

1. Mitochondrial Dysfunction: Mycotoxins disrupt mitochondrial function, leading to the leakage of electrons and the formation of superoxide anions, a type of ROS.

2. Activation of NADPH Oxidases: These enzymes generate superoxide by transferring electrons from NADPH to oxygen, further contributing to oxidative stress.

Impact of Oxidative Stress on Gut Health

Excessive ROS can cause significant damage to intestinal cells, affecting DNA, proteins, and lipids:

1. DNA Damage: ROS can cause mutations and strand breaks in DNA, potentially leading to cell death or cancer.

2. Protein Oxidation: Oxidative modifications can impair the function of essential proteins, including those involved in maintaining gut barrier integrity.

3. Lipid Peroxidation: ROS can damage cell membranes, leading to increased intestinal permeability and inflammation.

Functional Medicine Approaches to Mitigating Oxidative Stress

Functional medicine emphasizes holistic and preventive measures to counteract oxidative stress:

1. Dietary Antioxidants: Increasing intake of antioxidant-rich foods, such as fruits, vegetables, nuts, and seeds, helps neutralize ROS. Vitamins C and E, selenium, and polyphenols are particularly effective antioxidants.

2. Probiotics and Prebiotics: Enhancing gut health with probiotics and prebiotics can mitigate inflammation and support detoxification processes.

3. Detoxification Support: Supporting natural detoxification pathways with adequate hydration, liver-supportive nutrients, and binders can enhance mycotoxin elimination.

4. Lifestyle Modifications: Reducing exposure to mycotoxins through proper food storage, choosing organic foods, and avoiding moldy environments, along with regular exercise and stress management, can significantly improve gut health.

References

• Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical Microbiology Reviews, 16(3), 497–516. https://doi.org/10.1128/CMR.16.3.497-516.2003

• Frisvad, J. C., & Thrane, U. (2000). Mycotoxin production by common filamentous fungi. In R.A. Samson & E.S. Hoekstra (Eds.), Introduction to Food- and Airborne Fungi (6th ed., pp. 321-331). CBS-KNAW Fungal Biodiversity Centre. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88980/

• Peraica, M., Radic, B., Lucic, A., & Pavlovic, M. (1999). Toxic effects of mycotoxins in humans. Bulletin of the World Health Organization, 77(9), 754–766. https://www.who.int/bulletin/archives/77(9)754.pdf

• Smith, M. C., Madec, S., Coton, E., & Hymery, N. (2016). Natural co-occurrence of mycotoxins in foods and feeds and their in vitro combined toxicological effects. Toxins, 8(4), 94. https://doi.org/10.3390/toxins8040094

• Sinha, K. K., & Bhatnagar, D. (Eds.). (1998). Mycotoxins in Agriculture and Food Safety. Marcel Dekker Inc. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88980/

• Turner, P. C., Flannery, B., Isitt, C., Ali, M., & Pestka, J. (2012). The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutrition Research Reviews, 25(1), 162–179. https://doi.org/10.1017/S0954422412000012

• Viegas, S., Veiga, L., Almeida, A., Dos Santos, M., Carolino, E., & Viegas, C. (2016). Occupational exposure to mycotoxins in swine production: Environmental and biological monitoring approaches. Toxins, 8(12), 401. https://doi.org/10.3390/toxins8120401

• Wild, C. P., & Gong, Y. Y. (2010). Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis, 31(1), 71–82. https://doi.org/10.1093/carcin/bgp264

• Elamin, E., Masclee, A., Dekker, J., & Jonkers, D. “Mycotoxins: Mechanisms of Impaired Intestinal Barrier Function and Potential Health Implications.” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, 2013, pp. 133-140. PubMed, https://pubmed.ncbi.nlm.nih.gov/23020654/.

• Kelly, G. “Inulin-type Prebiotics—a Functional Medicine Approach to Gut Health.” Altern Med Rev, vol. 13, no. 4, 2008, pp. 315-329. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/19152481/.

• Sturgeon, C., & Fasano, A. “Zonulin, a Regulator of Epithelial and Endothelial Barrier Functions, and Its Involvement in Chronic Inflammatory Diseases.” Tissue Barriers, vol. 4, no. 4, 2016, Article e1251384. PubMed, https://pubmed.ncbi.nlm.nih.gov/27583155/.

• Cummings, J. H., & Macfarlane, G. T. “Role of Intestinal Bacteria in Nutrient Metabolism.” Clinical Nutrition 16.1 (1997): 3-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764127/.

• Turner, J. R. “Intestinal Mucosal Barrier Function in Health and Disease.” Nature Reviews Immunology 9.11 (2009): 799-809. https://www.nature.com/articles/nri2653.

• Wu, F., & Groopman, J. D. “Mycotoxins and Human Health: A Review.” Journal of Toxicology and Environmental Health, Part B 5.4 (2002): 281-292. https://www.tandfonline.com/doi/full/10.1080/10937400290070029.

• Liew, W. P. P., & Mohd-Redzwan, S. “Mycotoxin: Its Impact on Gut Health and Microbiota.” Frontiers in Cellular and Infection Microbiology 8 (2018): 60. https://www.frontiersin.org/articles/10.3389/fcimb.2018.00060/full.

• Ng, S. C., Lam, Y. T., Tsoi, K. K. F., & Chan, F. K. L. “Inflammatory Bowel Disease in Asia.” Journal of Gastroenterology and Hepatology 28.4 (2013): 801-807. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645393/.

• Ramos, A. J., & Hernández, E. “Prevention of Mycotoxins Contamination in Food Using Probiotics.” Frontiers in Microbiology 6 (2016): 148. https://www.frontiersin.org/articles/10.3389/fmicb.2015.01448/full.

• Kim, Y. G., Sakamoto, K., & Seo, S. S. “Effect of Dietary Polyphenols on the Intestinal Mucus Barrier.” Journal of Nutritional Biochemistry 25.2 (2014): 115-123. https://www.sciencedirect.com/science/article/pii/S0955286313002754.

• Richard, J. L. “Some Major Mycotoxins and Their Mycotoxicoses—An Overview.” International Journal of Food Microbiology 119.1-2 (2007): 3-10. https://www.sciencedirect.com/science/article/pii/S0168160507001767

• Turner, P. C., & Milićević, D. R. (2021). “Mycotoxins: Occurrence, Toxicity, and Human Health Risk.” Frontiers in Public Health, 9, 746755. https://doi.org/10.3389/fpubh.2021.746755

• Wu, F. (2019). “Mycotoxin Risk Assessment for Public Health.” Annual Review of Public Health, 40, 275-296. https://www.annualreviews.org/doi/10.1146/annurev-publhealth-040218-044508

• Maresca, M. (2013). “From the Gut to the Brain: Journey and Pathophysiological Effects of the Food-Associated Trichothecene Mycotoxin Deoxynivalenol.” Toxins, 5(4), 784-820. https://www.mdpi.com/2072-6651/5/4/784

• Wild, C. P., & Gong, Y. Y. (2010). “Mycotoxins and Human Disease: A Largely Ignored Global Health Issue.” Carcinogenesis, 31(1), 71-82. https://doi.org/10.1093/carcin/bgp264

• Alassane-Kpembi, I., Puel, O., & Oswald, I. P. (2015). “Toxicological Interactions between Mycotoxins in Food and Feed: A Review.” Food and Chemical Toxicology, 84, 141-153. https://doi.org/10.1016/j.fct.2015.08.021

• Pierron, A., Alassane-Kpembi, I., & Oswald, I. P. (2016). “Impact of Mycotoxin on Immune Response and Consequences for Pig Health.” Animal Nutrition, 2(2), 63-68. https://doi.org/10.1016/j.aninu.2016.03.001

• De Ruyck, Karolien, et al. “Human Exposure to Mycotoxins: A Global Overview of Occurrence and Biomonitoring.” Toxins, vol. 11, no. 6, 2019, pp. 1-36. PubMed, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616681/.

• Ferreira, Marisa S., et al. “Mycotoxins, oxidative stress and antioxidant responses: An overview.” Food and Chemical Toxicology, vol. 122, 2018, pp. 130-140. PubMed, https://www.ncbi.nlm.nih.gov/pubmed/29935208.

• Speijers, Gert J.A., and Marcel H. Speijers. “Combined toxic effects of mycotoxins.” Toxicology Letters, vol. 153, no. 1, 2004, pp. 91-98. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/15450432/.

• Marin, Sonia, et al. “Mycotoxins: Occurrence, toxicology, and exposure assessment.” Food and Chemical Toxicology, vol. 60, 2013, pp. 218-237. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/23994081/.

• Kovac, Jan, et al. “Probiotics can reduce the risk of mycotoxin contamination.” Gut Microbes, vol. 8, no. 1, 2017, pp. 1-4. PubMed, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372850/.

• Pinton, Philippe, and Isabelle P. Oswald. “Effect of Deoxynivalenol and other Type B Trichothecenes on the Intestine: A Review.” Toxins, vol. 6, no. 5, 2014, pp. 1615-1643. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/24859248/.

• Stoev, Stoycho D. “Food Safety and Preventive Measures to Control the Mycotoxin Contamination of Foods.” Toxins, vol. 7, no. 1, 2015, pp. 29-54. PubMed, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306765/.

• Frenich, A.G., et al. “Analytical methods for determination of mycotoxins: An overview.” Journal of Chromatography A, vol. 1217, no. 25, 2010, pp. 4223-4240. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/20381910/.

• Zain, Mohamed E. “Impact of mycotoxins on humans and animals.” Journal of Saudi Chemical Society, vol. 15, no. 2, 2011, pp. 129-144. National Institutes of Health, https://pubmed.ncbi.nlm.nih.gov/23960807/.